Technical Analysis for AVCO - Avalon GloboCare Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
2.41 | 0.42% | 0.01 |
AVCO closed up 0.42 percent on Friday, June 14, 2019, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| See historical AVCO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| Weak, Overbought and Reversal Signs | Reversal | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| 20 DMA Support | Bullish | 0.42% | |
| Stochastic Reached Overbought | Strength | 0.42% | |
| Weak + Overbought | Other | 0.42% | |
| Overbought Stochastic | Strength | 0.42% | |
| 20 DMA Support | Bullish | 4.78% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/03/2019
- Sector: Healthcare
- Industry: Medical Care
Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider. The Company engages in the management of stem cell banks and specialty clinical laboratories. It is developing of exosome technology to improve the diagnosis and management of diseases. The Company operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The Company also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable.
Medicine Diseases Disease Infectious Diseases Oncology Immunotherapy Regenerative Medicine Infectious Disease Exosome Fibrotic Diseases Vesicles
Medicine Diseases Disease Infectious Diseases Oncology Immunotherapy Regenerative Medicine Infectious Disease Exosome Fibrotic Diseases Vesicles
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 5 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more AVCO news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 13.5 |
| 52 Week Low | 1.77 |
| Average Volume | 148,163 |
| 200-Day Moving Average | 3.3638 |
| 50-Day Moving Average | 3.0248 |
| 20-Day Moving Average | 2.253 |
| 10-Day Moving Average | 2.178 |
| Average True Range | 0.2103 |
| ADX | 35.39 |
| +DI | 19.2057 |
| -DI | 24.2984 |
| Chandelier Exit (Long, 3 ATRs ) | 1.9791 |
| Chandelier Exit (Short, 3 ATRs ) | 2.4009 |
| Upper Bollinger Band | 2.5635 |
| Lower Bollinger Band | 1.9425 |
| Percent B (%b) | 0.75 |
| BandWidth | 27.563249 |
| MACD Line | -0.1677 |
| MACD Signal Line | -0.2573 |
| MACD Histogram | 0.0896 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.64 | ||||
| Resistance 3 (R3) | 2.62 | 2.53 | 2.60 | ||
| Resistance 2 (R2) | 2.53 | 2.47 | 2.54 | 2.58 | |
| Resistance 1 (R1) | 2.47 | 2.44 | 2.50 | 2.49 | 2.57 |
| Pivot Point | 2.38 | 2.38 | 2.40 | 2.39 | 2.38 |
| Support 1 (S1) | 2.32 | 2.32 | 2.35 | 2.34 | 2.25 |
| Support 2 (S2) | 2.23 | 2.29 | 2.24 | 2.24 | |
| Support 3 (S3) | 2.17 | 2.23 | 2.22 | ||
| Support 4 (S4) | 2.19 |
